TEVA Pharmaceuticals has announced an expansion of their global partnership, with a strong focus on new drug development as well as improving the management of chronic diseases.
Both e-Health projects will run on IBM's Watson Health Cloud, involving a three year research collaboration "to develop cognitive technologies that can enable a systematic approach to the emerging field of drug repurposing".
The alliance will "deliver unprecedented scale in the discovery of new uses for existing drugs," while the chronic disease management initiative will initially target respiratory and central nervous system diseases.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Oct 16
